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Abstract
Background: Gender influences the cardiac response to prolonged increases in workload, with differences at structural,
functional, and molecular levels. However, it is unknown if post-ischemic function or metabolism of female hypertrophied
hearts differ from male hypertrophied hearts. Thus, we tested the hypothesis that gender influences post-ischemic
function of pressure-overload hypertrophied hearts and determined if the effect of gender on post-ischemic outcome
could be explained by differences in metabolism, especially the catabolic fate of glucose.
Methods: Function and metabolism of isolated working hearts from sham-operated and aortic-constricted male and
female Sprague-Dawley rats before and after 20 min of no-flow ischemia (N = 17 to 27 per group) were compared.
Parallel series of hearts were perfused with Krebs-Henseleit solution containing 5.5 mM [5-3H/U-14C]-glucose, 1.2 mM
[1-14C]-palmitate, 0.5 mM [U-14C]-lactate, and 100 mU/L insulin to measure glycolysis and glucose oxidation in one series
and oxidation of palmitate and lactate in the second. Statistical analysis was performed using two-way analysis of variance.
The sequential rejective Bonferroni procedure was used to correct for multiple comparisons and tests.
Results:  Female gender negatively influenced post-ischemic function of non-hypertrophied hearts, but did not
significantly influence function of hypertrophied hearts after ischemia such that mass-corrected hypertrophied heart
function did not differ between genders. Before ischemia, glycolysis was accelerated in hypertrophied hearts, but to a
greater extent in males, and did not differ between male and female non-hypertrophied hearts. Glycolysis fell in all groups
after ischemia, except in non-hypertrophied female hearts, with the reduction in glycolysis after ischemia being greatest
in males. Post-ischemic glycolytic rates were, therefore, similarly accelerated in hypertrophied male and female hearts
and higher in female than male non-hypertrophied hearts. Glucose oxidation was lower in female than male hearts and
was unaffected by hypertrophy or ischemia. Consequently, non-oxidative catabolism of glucose after ischemia was lowest
in male non-hypertrophied hearts and comparably elevated in hypertrophied hearts of both sexes. These differences in
non-oxidative glucose catabolism were inversely related to post-ischemic functional recovery.
Conclusion: Gender does not significantly influence post-ischemic function of hypertrophied hearts, even though female
sex is detrimental to post-ischemic function in non-hypertrophied hearts. Differences in glucose catabolism may
contribute to hypertrophy-induced and gender-related differences in post-ischemic function.
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Background
There is substantial clinical and experimental evidence to
indicate that gender influences the myocardial response to
hemodynamic overload with female sex having a benefi-
cial effect [1-5]. In the clinical setting, for example, studies
have reported that females have increased cardiac hyper-
trophy, more concentric remodelling, and better preserva-
tion of left ventricular systolic function than males in
response to increased hemodynamic load, such as occurs
with aortic stenosis or hypertension [4,5]. Experimental
studies have also found differences in geometric remodel-
ling and cardiac function between hypertrophied hearts
from males and females similar to those observed in
humans [1-3]. This gender-related preservation of func-
tion in the setting of cardiac hypertrophy, which is a lead-
ing risk factor for development of heart failure [6],
translates into a lower overall incidence of heart failure in
females than in males [7].
Despite having a beneficial effect on cardiac remodelling
due to hemodynamic overload, female sex is associated
with greater rates of heart failure in the presence of symp-
tomatic coronary artery disease [7,8]. This finding is con-
sistent with clinical data indicating that, although of
lower incidence in women, coronary artery disease is par-
ticularly problematic once present. Correspondingly,
females have an increased risk of a poor outcome after
coronary revascularization procedures [7,9,10] and
younger women have worse short-term outcomes after
acute myocardial ischemia leading to infarction than men
[11,12]. Furthermore, the presence of left ventricular
hypertrophy has been shown to have a detrimental
impact on mortality due to ischemic heart disease that is
greater in women than in men [13]. Taken together, these
data indicate that female sex influences remodelling due
to hemodynamic overload as well as outcome after
ischemia. They also suggest that the functional signifi-
cance of simultaneously occurring cardiac hypertrophy
and coronary artery disease differs between women than
in men.
Cardiac hypertrophy due to hemodynamic overload has
generally been viewed as an adaptive response [14,15].
However, it can also be considered maladaptive. This lat-
ter consideration becomes especially apparent when
hypertrophied hearts are exposed to ischemia and reper-
fusion, a situation that results in significantly lower post-
ischemic heart function in hypertrophied hearts than in
non-hypertrophied hearts [16-19]. Currently, the detri-
mental effect of hypertrophy on post-ischemic heart func-
tion is well documented in hypertrophied hearts from
males. To our knowledge, functional outcome of pressure-
overload hypertrophied hearts after ischemia in females
and whether cardiac hypertrophy is more or less detri-
mental to outcome in females than in males are not yet
known with certainty. Such information would provide
important insights into the apparent additive effects of
cardiac hypertrophy and ischemic heart disease in females
observed clinically.
As in non-hypertrophied hearts [20], the catabolic fate of
exogenous glucose is recognized as an important factor
that contributes to the poor post-ischemic function of
hypertrophied hearts, at least in hypertrophied hearts
from males [16-19,21,22]. Specifically, the extent to
which glucose passing through glycolysis is catabolized
non-oxidatively (i.e, is converted to lactate rather to CO2)
appears to be of functional significance, as rates of non-
oxidative glycolysis are inversely related to post-ischemic
function of male hypertrophied and non-hypertrophied
hearts [22]. An acceleration of overall glycolysis combined
with a limitation of glucose oxidation [19,23,24] result in
increased rates of non-oxidative glycolysis in hypertro-
phied male hearts [22]. That accelerated rates of non-oxi-
dative glycolysis contribute to the poor outcome of
hypertrophied hearts after ischemia is supported by data
showing that stimulation of glucose oxidation and/or
reduction of glycolysis, effects that alone or in combina-
tion reduce non-oxidative glycolysis, substantially
improve function of ischemic-reperfused hypertrophied
hearts from male rats [19,22]. At this time, it is not yet
clearly known if female gender influences the pattern of
substrate use and particularly of glucose use in pressure-
overload hypertrophied hearts either before or after
ischemia.
In the experiments described here, we tested the hypothe-
sis that gender influences post-ischemic functional recov-
ery of pressure-overload hypertrophied hearts. Given the
importance of substrate use to post-ischemic recovery of
hypertrophied heart function in males, we also deter-
mined if substrate use in female hypertrophied hearts dif-
fered from that in male hypertrophied hearts and, if so,
whether any differences could be explained by alteration
in expression or activity of key enzymes and proteins
involved in control of myocardial substrate use.
Methods
Animal model
A mild pressure-overload left ventricular hypertrophy was
produced in male and female Sprague-Dawley rats by con-
striction of the suprarenal abdominal aorta with a metal-
lic clip (0.4 and 0.3 mm diameter, respectively) at 3 weeks
of age [23]. In sham-operated control rats, the aorta was
isolated, but not clipped. Experiments were performed 8
weeks after surgery. Food and water were administrated ad
libitum. These experiments were approved by the institu-
tional committee on the use of laboratory animals in
research and conform with the Guide for the Care and UseBMC Cardiovascular Disorders 2006, 6:8 http://www.biomedcentral.com/1471-2261/6/8
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of Laboratory Animals by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1986).
A subset of anesthetized (ketamine/xylazine, 90/10 mg/
kg, IP) male and female rats with and without aortic con-
striction were studied 8 weeks after surgery in order to
determine if gender influenced the pressure load in this
model. Mean arterial pressure and heart rate were deter-
mined by means of a micromanometer-tipped catheter
(SPR-838, Millar Instruments, Houston, TX) in the left
carotid artery.
Isolated heart preparation and perfusion protocol
As previously described [19,23], isolated working hearts
from aortic-constricted and sham-operated rats were per-
fused at a left atrial preload of 11.5 mmHg and an aortic
afterload of 80 mmHg in a closed recirculating system
with oxygenated (95% O2-5% CO2) Krebs-Henseleit (KH)
solution. Hearts were all perfused under comparable con-
ditions in order to avoid potentially confounding effects
of exposure to different afterloads. Although hearts from
aortic-constricted rats are exposed to elevated afterloads in
vivo, we have shown that adjusting afterload to normalize
coronary flow per gram in isolated working hypertrophied
hearts does not significantly influence the functional or
metabolic outcomes observed after ischemia [25]. The KH
solution contained 1.2 mM palmitate prebound to fatty
acid-free albumin (3%), 5.5 mM glucose, 0.5 mM lactate,
2.5 mM calcium, and 100 mU/l insulin and was main-
tained at 37°C. A high physiologic concentration of insu-
lin was used in order to ensure that insulin-dependent
glucose uptake was not limiting. The concentration of
palmitate was chosen in order to recapitulate conditions
observed during reperfusion after ischemia [20]. Heart
rate, peak systolic pressure, cardiac output and aortic flow
were measured every 10 min of the working heart per-
fusion. Coronary flow and indices of external cardiac
work, including rate-pressure product and hydraulic
power, were calculated as described [19,23].
Hearts were initially perfused for 30 min under normoxic
non-ischemic conditions followed by a 20 min period of
global ischemia that was induced by clamping both the
left atrial preload and aortic afterload lines. At the end of
ischemia, the clamps were removed and the hearts were
reperfused for 40 min. We have previously shown that
function is stable in isolated working hearts perfused
under non-ischemic, normoxic conditions for 90 min
[26]. At the end of reperfusion, hearts were quickly frozen
using tongs cooled to the temperature of liquid nitrogen.
Frozen heart tissue was weighed with a portion of ven-
tricular tissue used to determine the dry-to-wet tissue
weight ratio.
Measurement of myocardial substrate utilization and 
glycogen content
Myocardial substrate utilization was measured in two par-
allel series in each group. In the first series of experiments,
hearts were perfused with [5-3H]-glucose and [U-14C]-glu-
cose in order to determine rates of glycolysis and glucose
oxidation, respectively, as previously described [23,27]. In
the second series of experiments performed under identi-
cal conditions, rates of lactate and palmitate oxidation
were determined by perfusing the hearts with [U-14C]-lac-
tate and [9,10-3H] palmitate [23,27]. It should be noted
that these rates refer to catabolic rates of exogenous sub-
strates, as the contribution of endogenous substrates, such
as glycogen, was not taken into account. Rates of glycoly-
sis and palmitate oxidation were determined by quantita-
tively measuring the rate of 3H2O production. Rates of
glucose and lactate oxidation were measured by quantita-
tive collection of 14CO2 released as a gas and dissolved in
the perfusate as [14C]-bicarbonate. Perfusate and gaseous
samples were taken every 10 min of perfusion and were
ultimately placed in vials containing scintillation cocktail
and counted by standard techniques. Pre-ischemic values
for all metabolic rates were calculated based on data col-
lected between 10 and 30 min, while post-ischemic values
were calculated between 10 and 40 min of reperfusion.
Rates of non-oxidative glycolysis were calculated as the
difference between rates of glycolysis and glucose oxida-
tion [22]. Myocardial glycogen was determined by meas-
uring glucose obtained following digestion of frozen
powdered ventricular tissue with 30% KOH, ethanol pre-
cipitation, and acid hydrolysis of glycogen [28].
Content and activity of selected myocardial metabolic 
proteins and pnzymes
The content of selected enzymes and proteins involved in
control of myocardial substrate utilization was deter-
mined by immunoblot analysis using a previously
described method [26,29]. The particular proteins and
enzymes assessed were chosen based upon either recogni-
tion as having significant control strength for the meta-
bolic pathway in question and/or reported alteration in
models of cardiac hypertrophy. Briefly, samples of frozen
ventricular tissue homogenate (containing 20 µg total
protein) were solubilized by boiling in reducing sample
buffer, separated by electrophoresis on 10% SDS-polyacr-
ylamide gels, and transferred by electroblotting to a nitro-
cellulose membrane. After non-specific blocking, the
blots were probed overnight with the following primary
antibodies: rabbit anti-GLUT-4 (1:1500 dilution, Cell Sig-
nalling Technology, Missisauga, Ontario), mouse anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH,
1:200,000 dilution, Molecular Probes, Eugene, Oregon),
rabbit anti-α- and β-enolase (1:5,000 and 1:75,000 dilu-
tion, respectively [30], rabbit anti-muscle type phosphof-
ructokinase (PFK, 1:3,000 dilution [31], rabbit anti-BMC Cardiovascular Disorders 2006, 6:8 http://www.biomedcentral.com/1471-2261/6/8
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pyruvate dehydrogenase complex (PDC, 1:4,000 dilution,
[32], rabbit anti-medium-chain (MCAD, 1:4,000 dilu-
tion) and anti-long-chain (LCAD, 1:5,000 dilution) acyl-
CoA dehydrogenases [33]. After incubation with the
appropriate secondary antibody, the signal was detected
by an ECL based detection system. Band intensity values
for each individual protein were quantified by densitom-
etry. For each protein of interest, GAPDH was sequentially
detected for purposes of normalization. Background-cor-
rected densitometry values for the protein of interest and
GAPDH were used to calculate relative expression ratios.
Activity of PDC was determined as described [32].
Statistical analysis
Analysis was performed using SPSS version 7.0. Weight,
glycogen, expression, and activity data were analyzed
using two-way analysis of variance (ANOVA). Left ven-
tricular function, glycolysis, and oxidation of glucose, lac-
tate, and palmitate were examined using two-way
repeated measures ANOVA. A log transformation of data
was used, when necessary, to satisfy homogeneity of vari-
ance assumption for ANOVA. The sequential rejective
Bonferroni procedure was used to correct for multiple
comparisons and tests. A corrected p value > 0.05 was con-
sidered as non-significant. Data are expressed as means
value ± SEM.
Results
Animal model
Morphologic and in vivo hemodynamic data are summa-
rized in Table 1. Eight weeks after surgery, heart weight in
male and female aortic constricted rats was approximately
20% greater than sex-matched sham-operated control
rats. There was no significant difference in body weight
between aortic-constricted and sham-operated rats of
either sex. Heart and body weights of female rats were sig-
nificantly lower than that of male rats. As with heart
weight, the ratio of heart weight and body weight showed
a comparable percent increase in both male (20.1 ± 2.3%)
and female (24.0 ± 1.9%, p = NS) aortic-constricted rats.
Aortic constriction resulted in significant increases in
mean aortic pressure in both male and female rats but had
no effect on heart rate. Mean aortic pressure did not differ
between male and female sham-operated control rats or
between male and female rats with aortic constriction.
Heart function
Heart function is summarized in Table 2. Before ischemia,
cardiac output, hydraulic power, and coronary flow were
lower in male hypertrophied hearts than corresponding
values in male non-hypertrophied hearts. In contrast,
only coronary flow was lower in hypertrophied hearts
from female rats than in non-hypertrophied hearts from
female rats. Other than higher coronary flow rates in
females, there were no significant differences in function
between male and female hypertrophied hearts. In non-
Table 1: Morphologic and hemodynamic data of hearts from sham-operated and aortic-constricted rat hearts
Male Female
Control Hypertrophy Control Hypertrophy
Body wt (g) 451 ± 5 453 ± 10 278 ± 5$ 271 ± 5*$
Heart wt (g) 1.86 ± 0.02 2.23 ± 0.04* 1.28 ± 0.04$ 1.55 ± 0.03*$
Heart/body wt 4.1 ± 0.04 4.95 ± 0.09* 4.61 ± 0.11$ 5.72 ± 0.09*$
Heart rate (bpm) 262.5 ± 7.4 255.8 ± 3.0* 260.4 ± 10.1 255.4 ± 10.5*
Mean aortic pressure (mm Hg) 109.6 ± 7.0 164.6 ± 7.3 96.3 ± 6.0 153.1 ± 5.8
Values are Mean ± SEM. Sham-operated rats, Control. Aortic-constricted rats, Hypertrophy. Numbers for morphologic data are 18–36 per group 
and for hemodynamic data are 6–8 per group; * vs. Sex-matched Control, p < 0.05; $vs. corresponding Male value, p < 0.05.
Table 2: Heart function data in hearts from sham-operated and aortic-constricted rat hearts
Male Control Male Hypertrophy Female Control Female Hypertrophy
Pre-I Post-I Pre-I Post-I Pre-I Post-I Pre-I Post-I
Heart Rate (bpm) 253 ± 4 261 ± 5 247 ± 5 242 ± 10 250 ± 3 214 ± 7#$ 251 ± 5 182 ± 11#*$
Peak Systolic Pressure (mmHg) 111 ± 1 100 ± 2# 109 ± 2 95 ± 2# 108 ± 1 91 ± 4# 108 ± 1 89 ± 4#$
Cardiac Output (ml/min) 69 ± 2 47 ± 3# 56 ± 2* 31 ± 4#* 55 ± 1$ 25 ± 2#$ 53 ± 2 20 ± 2#$
Coronary Flow (ml/min g wet wt) 16 ± 1 13 ± 1# 10 ± 1* 6 ± 1#* 20 ± 1$ 11 ± 1#$ 14 ± 1*$ 6 ± 1#*
Rate Pressure Product (bpm × mmHg × 10-3) 28 ± 1 26 ± 1# 27 ± 1 24 ± 1#* 27 ± 1 20 ± 1#$ 27 ± 1 17 ± 1#$
Hydraulic Power (ml/min × mmHg × 10-3) 77 ± 3 48 ± 4# 62 ± 3* 30 ± 4#* 59 ± 2$ 24 ± 2#$ 57 ± 2 19 ± 2#*$
Values are Mean ± SEM. Non-hypertrophied heart, Control. Hypertrophied heart, Hypertrophy. Pre-I, Pre-ischemia; Post-I, Post-ischemia; *, vs 
Sex-matched Control; #, vs pre-Ischemic values; $, vs corresponding Male value; all at p < 0.05.BMC Cardiovascular Disorders 2006, 6:8 http://www.biomedcentral.com/1471-2261/6/8
Page 5 of 13
(page number not for citation purposes)
hypertrophied hearts, cardiac output and hydraulic power
were higher in males than in females, while coronary flow
was highest in females.
Functional parameters, except for heart rate in males, were
reduced in all groups after ischemia as compared to corre-
sponding pre-ischemic values. Post-ischemic function of
hypertrophied hearts from both male and female rats was
lower than corresponding non-hypertrophied hearts.
Hypertrophied heart function after ischemia in females
was lower than that in male hypertrophied hearts, except
for post-ischemic coronary flow rates which did not differ
between male and female hypertrophied hearts. All func-
tional parameters in reperfused female non-hypertro-
phied hearts, except peak systolic pressure, were
significantly lower than those in male non-hypertrophied
hearts during reperfusion. The differences in post-
ischemic function between male and female hearts
remained when function was corrected for heart weight
(Figure 1), except that function during reperfusion no
longer differed significantly between male and female
hypertrophied hearts. Compared to pre-ischemic values,
recovery of function was lower in female hypertrophied
(33.4 ± 4.1%) and non-hypertrophied (40.2 ± 4.3%)
hearts than in corresponding male hypertrophied (48.4 ±
6.2%) and non-hypertrophied (64.4 ± 4.5%) hearts (p <
0.05). When external cardiac work is expressed relative to
gender-matched non-hypertrophied hearts as a means to
account for gender-related differences in function, post-
ischemic functional recovery is comparably reduced in
male (77.0 ± 9.5%) and female (83.0 ± 10.1%) hypertro-
phied hearts as compared to pre-ischemic values indicat-
ing that the impact of hypertrophy on post-ischemic
recovery is similar in both genders.
Myocardial substrate utilization
Glycolysis
Prior to ischemia, glycolysis was higher in hypertrophied
hearts than in non-hypertrophied hearts from male and
female rats (Figure 2A). Rates of glycolysis were greater in
hypertrophied hearts from males than from females,
while differences in glycolysis were not observed between
male and female non-hypertrophied hearts. After
ischemia, rates of glycolysis were significantly lower than
pre-ischemic values in all groups except non-hypertro-
phied hearts from female rats. Glycolysis was, therefore,
higher in female non-hypertrophied hearts than in male
non-hypertrophied hearts. Rates of glycolysis continued
to be accelerated in hypertrophied hearts after ischemia in
males and females with rates in male and female hypertro-
phied hearts no longer significantly different.
Glucose oxidation
Before ischemia, glucose oxidation was higher in male
non-hypertrophied and hypertrophied hearts than in cor-
responding hearts from female rats (Figure 2B). Rates in
hypertrophied hearts did not differ from those in non-
hypertrophied hearts in either sex. Glucose oxidation after
ischemia was not different from rates before ischemia in
any group.
Palmitate oxidation
Prior to ischemia, rates of palmitate oxidation were
approximately 30% lower in hypertrophied hearts than in
non-hypertrophied hearts from both male and female rats
(Figure 2C). Sex of the animal did not influence palmitate
oxidation rates in either non-hypertrophied or hypertro-
phied hearts before ischemia. In males, post-ischemic
rates of palmitate oxidation in hypertrophied and non-
hypertrophied hearts did not differ from those before
ischemia. In contrast, palmitate oxidation decreased in
hearts from female rats after ischemia compared to pre-
ischemic values such that palmitate oxidation was signifi-
cantly lower in hypertrophied hearts from females than in
male hypertrophied hearts.
Lactate oxidation
Compared to corresponding non-hypertrophied hearts,
lactate oxidation before ischemia was lower in male
hypertrophied hearts but was not different in female
hypertrophied hearts (Figure 2D). Rates of lactate oxida-
Post-ischemic mass-corrected function of hypertrophied and  non-hypertrophied hearts from male and female rats Figure 1
Post-ischemic mass-corrected function of hypertrophied and 
non-hypertrophied hearts from male and female rats. Open 
circle, male non-hypertrophied hearts; open square, male 
hypertrophied hearts; filled circle, female non-hypertrophied 
hearts; filled square, female hypertrophied hearts. *, vs. sex-
matched non-hypertrophied hearts (p < 0.05). #, vs. corre-
sponding male hearts (p < 0.05). Numbers per group: 27 
male non-hypertrophied hearts, 21 male hypertrophied 
hearts, 17 female non-hypertrophied hearts, and 18 female 
hypertrophied hearts. Values are mean ± SEM.
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tion were higher in male than in female non-hypertro-
phied hearts. Lactate oxidation, therefore, did not differ in
hypertrophied hearts from male and female rats. In male
hypertrophied hearts, lactate oxidation after ischemia did
not differ from that before ischemia. Lactate oxidation
after ischemia increased in female hearts as compared to
pre-ischemic values, achieving significance only in hyper-
trophied hearts. Post-ischemic rates of lactate oxidation in
female hypertrophied hearts were now higher than those
in hypertrophied hearts from male rats.
Non-oxidative glycolysis
Prior to ischemia, non-oxidative glycolysis was higher in
hypertrophied hearts than corresponding non-hypertro-
phied hearts in both sexes with rates in hypertrophied
hearts from males greater than those from females (Table
3). Rates did not differ between male and female non-
hypertrophied hearts. Non-oxidative glycolysis was higher
in hypertrophied hearts than non-hypertrophied hearts
but rates no longer differed between male and female
hypertrophied hearts after ischemia. On the other hand,
Glycolysis (A), glucose oxidation (B), palmitate oxidation (C), and lactate oxidation (D) in hypertrophied and non-hypertro- phied hearts from male and female rats Figure 2
Glycolysis (A), glucose oxidation (B), palmitate oxidation (C), and lactate oxidation (D) in hypertrophied and non-hypertro-
phied hearts from male and female rats. White bar, male non-hypertrophied hearts; black bar, male hypertrophied hearts; light 
grey bar, female non-hypertrophied hearts; dark grey bar, female hypertrophied hearts. *, vs. sex-matched non-hypertrophied 
hearts at same time period (p < 0.05). #, vs. pre-ischemic value (p < 0.05). $, vs. corresponding male hearts at same time 
period (p < 0.05). Numbers per group: 12 to 16 male non-hypertrophied hearts, 8 to 14 male hypertrophied hearts, and 6 to 8 
female non-hypertrophied hearts, 6 to 8 female hypertrophied hearts. Values are mean ± SEM.
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rates of post-ischemic non-oxidative glycolysis were sig-
nificantly higher in non-hypertrophied hearts from
females than from males. Of importance, recovery of
heart function after ischemia showed a significant inverse
relationship with rates of non-oxidative glycolysis (Figure
3).
Myocardial glycogen
Content of glycogen did not differ between non-hypertro-
phied and hypertrophied hearts at the end of reperfusion
in either males (136 ± 10 vs. 152 ± 9 µmol/g dry wt, p =
NS) or females (118 ± 12 vs. 110 ± 8 µmol/g dry wt, p =
NS). Myocardial glycogen was lower in female hearts than
in male hearts, but was significantly lower only in female
hypertrophied hearts as compared to male hypertrophied
hearts (p < 0.05).
Myocardial content and activity of selected metabolic 
proteins and enzymes
Differences in expression of key enzymes and proteins
involved in glucose and fatty acid metabolism were not
observed between male hypertrophied and non-hypertro-
phied hearts (Figures 4 and 5). In contrast, expression of
PFK-1 and enolase-β was increased and decreased, respec-
tively, in female hypertrophied hearts compared to non-
hypertrophied hearts from female rats (Figures 4 and 6).
As in males, differences in expression of MCAD and LCAD
were not observed between female hypertrophied and
non-hypertrophied hearts (Figure 5). Only minor sex-
related differences in myocardial expression of these pro-
teins and enzymes were detected (Figure 6). Specifically,
expression of enolase-α, relative to GAPDH, was higher,
while that of PDC E1α was lower in male hearts than in
female hearts, regardless of the presence or absence of
hypertrophy. Activity of PDC was not significantly differ-
ent between hypertrophied and non-hypertrophied hearts
in males (16.10 ± 2.27 vs. 14.48 ± 0.28 nmol min-1 mg
protein-1) or females (12.60 ± 1.12 vs. 15.97 ± 5.08 nmol
min-1 mg protein-1). There were also no significant gender
related differences in activity of PDC.
Discussion
Gender, hypertrophy, and heart function
In the current study, gender was not found to significantly
influence post-ischemic recovery of function in pressure
overload hypertrophied hearts. Differences in post-
ischemic function occurred largely because female sex was
associated with greater dysfunction after ischemia than
male sex. Interestingly, when compared to sex-matched
non-hypertrophied hearts, the degree of functional
impairment in female hypertrophied hearts was compara-
ble to that in male hypertrophied hearts (Table 2 and Fig-
ure 1), indicating that the detrimental effect of
hypertrophy on function after acute ischemia is similar in
females than in males.
Few experimental studies have specifically compared the
functional outcome of non-hypertrophied hearts from
Relationship of post-ischemic contractile function to rates of  non-oxidative glycolysis in hypertrophied and non-hypertro- phied hearts from male and female rats Figure 3
Relationship of post-ischemic contractile function to rates of 
non-oxidative glycolysis in hypertrophied and non-hypertro-
phied hearts from male and female rats. Percent (%) Recov-
ery of left ventricular external work was calculated as the 
quotient of post-ischemic and pre-ischemic hydraulic power 
multiplied by 100. Non-oxidative glycolysis was calculated as 
the difference between rates of glycolysis and glucose oxida-
tion. Regression analysis was performed using data from indi-
vidual hearts (N = 33 hearts; R = -0.49, p < 0.05) and is 
expressed as mean data per group (N = 5 to 12 per group). 
Values are mean ± SEM. Open circle, Male Control. Closed 
circle, Male hypertrophy. Open square, Female Control. 
Closed square, Female Hypertrophy.
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Table 3: Non-oxidative glycolysis in hearts from sham-operated and aortic-constricted rats
Male Female
Control Hypertrophy Control Hypertrophy
Pre-ischemic 2504 ± 180 4224 ± 231* 2274 ± 167 3017 ± 152*$
Post-ischemic 1259 ± 109# 2748 ± 187#* 2011 ± 144$ 2595 ± 144#*
Values are Mean ± SEM. Sham-operated rats, Control. Aortic-constricted rats, Hypertrophy. Numbers are 5–18 per group; * vs. Sex-matched 
Control, p < 0.05; $ vs. corresponding Male heart at the same time period, p < 0.05; # vs. pre-ischemic value, p < 0.05.BMC Cardiovascular Disorders 2006, 6:8 http://www.biomedcentral.com/1471-2261/6/8
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males and females after ischemia and reperfusion. In
keeping with our results, Glick et al [34] found that post-
ischemic functional recovery of isolated working hearts
from female rats is lower than that of hearts from male
rats when hearts are perfused with a solution containing
glucose and fatty acid, a heart preparation and a perfusate
composition very similar to that used in the current inves-
tigation. Our finding of a reduced functional recovery in
female hearts after ischemia is also consistent with clinical
data showing that women are at greater risk than men of
a poor outcome after myocardial ischemia or revasculari-
zation procedures [7,9-12].
Gender-related differences in function of hypertrophied
and non-hypertrophied hearts prior to ischemia were also
observed. Pre-ischemic function of hypertrophied hearts
was better maintained in female rats than in male rats, a
finding that is entirely consistent with data from both
clinical [1,4,35] and experimental [1-3] studies showing
that female gender beneficially influences the myocardial
response to hemodynamic overload. That the relative
increase in heart mass did not differ significantly between
male and female aortic-constricted rats is also consistent
with previous work in which heart mass was shown to be
similar in males and females early in the progression of
experimental hypertensive heart disease [2].
Gender, hypertrophy, and myocardial substrate utilization
Gender-related differences in myocardial substrate utiliza-
tion were observed in hypertrophied and non-hypertro-
phied hearts before and after ischemia (Figure 2).
Glycolysis was accelerated in hypertrophied hearts,
regardless of sex, although the degree of acceleration was
less in females than in males (Figure 2A). This accelera-
tion of glycolysis is consistent with previous data from
hypertrophied male rat hearts in vitro [19,23] and from
Representative immunoblots of key myocardial enzymes and proteins involved in glucose metabolism in non-hypertrophied  (Control) and hypertrophied (Hypertrophy) hearts from male (Male Pathologic Hypertrophy) and female (Female Pathologic  Hypertrophy) hearts Figure 4
Representative immunoblots of key myocardial enzymes and proteins involved in glucose metabolism in non-hypertrophied 
(Control) and hypertrophied (Hypertrophy) hearts from male (Male Pathologic Hypertrophy) and female (Female Pathologic 
Hypertrophy) hearts. Each lane represents a single heart. GLUT-4, glucose transport protein-4; HKII, hexokinase-II; PFK-1, 
phosphofructokinase-1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PDC E1α, pyruvate dehydrogeanse complex 
E1α subunit.
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Glucose
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Control Hypertrophy Control Hypertrophy
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hypertrophied dog [36] and rat [37] hearts in vivo. In male
hypertrophied hearts, enhanced glycolytic rates were not
accompanied by changes in expression of key metabolic
enzymes and proteins (Figure 4), a finding that contrasts
with previous observations that activity of a number of
glycolytic enzymes is enhanced in hearts exposed to a
pressure overload, albeit in different species [38,39].
Female hypertrophied hearts, on the other hand, demon-
strated elevation of PFK-1, an enzyme having significant
control strength for glycolytic flux, but a reduction in
expression of another glycolyitc enzyme, enolase-β (Fig-
ures 4 and 6), the latter finding having been described pre-
viously in hypertrophied hearts from female rats [40].
In general, oxidation of glucose (Figure 2B) and, to a
lesser extent, lactate (Figure 2D) was lower in female
hearts than in male hearts, except after ischemia, where
lactate oxidation rates in female hypertrophied hearts
were higher than in corresponding male hearts. As with
glycolysis, there was poor correspondence between meas-
ured rates of flux through the PDC, an enzyme that con-
tributes significantly to the control of myocardial glucose
and lactate oxidation, with its expression (Figure 4) and
activity. That the patterns of use differ between glucose
and lactate likely reflects the potential for fates of pyruvate
derived from glucose and lactate to differ [41].
Myocardial glycogen did not differ between hypertro-
phied and non-hypertrophied hearts of either sex at the
end of reperfusion, a finding in keeping with previous
data obtained in male rats [19]. That glycogen content was
lower in female hearts compared to male hearts may be a
reflection of differences in the dynamic response of myo-
cardial glycogen between males and females previously
reported [42]. As glycogen is known to contribute signifi-
cantly to energy production in male non-hypertrophied
and hypertrophied hearts [28,43], gender-related differ-
ences in glycogen metabolism could have contributed to
the functional differences observed in the current study.
Fatty acid oxidation was depressed in male and female
hypertrophied hearts compared to corresponding non-
hypertrophied hearts (Figure 2C), a finding consistent
with previous results in hypertrophied hearts from male
rats [23,44,45]. Despite reductions in measured rates of
fatty acid oxidation, expression of MCAD and LCAD (Fig-
ure 5), key enzymes in the mitochondrial β-oxidation spi-
ral, was not significantly altered in this model of mild
compensated cardiac hypertrophy. The fall in fatty acid
oxidation rates in female hearts after ischemia may be
related to lower contractile function, as the differences
disappear when fatty acid oxidation rates are normalized
to work performed by the heart (data not shown). Nota-
bly, the pattern of use of the other myocardial substrates
is not altered significantly when cardiac workload is
accounted for. Taken together, hypertrophy-associated
changes in substrate utilization rates and differences in
substrate utilization between male and female hypertro-
phied hearts are not adequately accounted for by altera-
tions in expression of metabolic enzymes and proteins,
indicating that other factors, such as allosteric and/or cov-
alent modification, translocation of glucose, fatty acid, or
lactate transporters, substrate content, and product inhibi-
tion, are likely responsible.
Post-ischemic heart function and myocardial substrate 
utilization
There is good evidence from experimental and clinical
studies to indicate that the catabolic fate of glucose, and
in particular the relative extent to which glucose is cat-
abolized oxidatively as compared to non-oxidatively, is an
important determinant of post-ischemic myocardial func-
Representative immunoblots of myocardial enzymes and proteins involved in fatty acid oxidation in non-hypertrophied (Con- trol) and hypertrophied (Hypertrophy) hearts from male (Male Pathologic Hypertrophy) and female (Female Pathologic Hyper- trophy) hearts Figure 5
Representative immunoblots of myocardial enzymes and proteins involved in fatty acid oxidation in non-hypertrophied (Con-
trol) and hypertrophied (Hypertrophy) hearts from male (Male Pathologic Hypertrophy) and female (Female Pathologic Hyper-
trophy) hearts. Each lane represents a different heart. MCAD, medium chain acyl-CoA dehydrogenase; LCAD, long-chain acyl-
CoA dehydrogenase.
Female Pathologic Hypertrophy Male Pathologic Hypertrophy
Control Hypertrophy Control Hypertrophy
MCAD
LCADBMC Cardiovascular Disorders 2006, 6:8 http://www.biomedcentral.com/1471-2261/6/8
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tion in non-hypertrophied and hypertrophied hearts
[19,20,22]. Substantial differences in non-oxidative glyc-
olysis were observed among groups in the current study
(Table 3). These differences were the result of gender-spe-
cific alterations in glucose catabolism with differences in
the response of glycolysis to ischemia-reperfusion
between male and female hearts being especially impor-
tant because glucose oxidation rates were not similarly
affected (Figure 2A and Table 3). Besides calculation from
rates of glycolysis and glucose oxidation, non-oxidative
glycolysis can also be determined from release of lactate
and pyruvate by the heart, a parameter not measured in
the current experiments. Results from previous studies
indicate that an excellent correspondence exists between
these two parameters [46].
When present, differences in non-oxidative glycolysis
were accompanied by differences in post-ischemic func-
tion (Table 3 and Figure 1). In fact, we found a significant
inverse relationship between non-oxidative glycolysis and
recovery of contractile function after ischemia (Figure 3).
The mechanism(s) by which non-oxidative glycolysis
Densitometric analysis of selected myocardial enzymes and proteins involved in myocardial glucose metabolism in non-hyper- trophied and hypertrophied hearts from male and female rats Figure 6
Densitometric analysis of selected myocardial enzymes and proteins involved in myocardial glucose metabolism in non-hyper-
trophied and hypertrophied hearts from male and female rats. (A) Enolase-α, (B) Enolase-β, (C) phosphofructokinase-1, and 
(D) pyruvate dehydrogeanse complex E1α subunit. White bar, male non-hypertrophied hearts; black bar, male hypertrophied 
hearts; light grey bar, female non-hypertrophied hearts; dark grey bar, female hypertrophied hearts. *, vs. sex-matched non-
hypertrophied hearts (p < 0.05). $, vs. corresponding male hearts (p < 0.05). Values are expressed in arbitrary densitometry 
units, normalized to corresponding GAPDH densitometry units obtained from the same immunoblot. Numbers per group: 12 
to 16 male non-hypertrophied hearts, 8 to 14 male hypertrophied hearts, and 6 to 8 female non-hypertrophied hearts, 6 to 8 
female hypertrophied hearts. Values are mean ± SEM.
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influences contractile function during reperfusion is not
yet fully known. However, based upon the different pro-
ton stoichiometry of non-oxidative glucose catabolism as
compared to glucose oxidation, which indicates 2 moles
of protons are produced per mole of glucose catabolized
non-oxidatively when the ATP formed is hydrolyzed
[47,48], one possibility is that it is related to differences in
net proton (H+) production arising from glucose catabo-
lism [20]. Accelerated rates of H+ production have been
proposed to lead to increased calcium (Ca2+) overload as
a result of successive trans-sarcolemmal H+/sodium (Na+)
and Na+/Ca2+ exchange, which in turn increases the ener-
getic cost associated with the maintenance of ion homeos-
tasis and, in doing so, leads to reduced post-ischemic
contractile function and efficiency [20,49]. Future studies,
in which pH and concentration of Na+ and Ca2+ in the
myocardium of male and female hypertrophied and non-
hypertrophied hearts are directly measured, will be
required to determine if this is the case.
Other potential mechanisms
In addition to variability in non-oxidative glycolysis,
other factors likely contribute to the differences in post-
ischemic contractile function observed. Following
ischemia, coronary flow was significantly lower in non-
hypertrophied hearts from female rats than in corre-
sponding hearts from male rats (Table 2), a finding that
may account in part for the poor recovery of female com-
pared to male non-hypertrophied hearts. Lower rates of
coronary flow in hypertrophied hearts than in non-hyper-
trophied hearts in both sexes may contribute to the
reduced function in these hearts compared to correspond-
ing non-hypertrophied hearts. Additionally, the genomic
response to pressure overload is known to differ between
hearts from males and females [50] with differential
expression of a number of proteins relevant to functional
outcome after ischemia, such as heat shock protein iso-
forms [51], ATP sensitive potassium channels [52], and
sarcoplasmic reticulum calcium ATPase [52], having been
described. The extent to which differences in expression of
such proteins contribute to the post-ischemic outcomes of
male and female hypertrophied hearts remains to be
determined.
Methodological considerations
The catabolism of endogenous substrates, such as glyco-
gen and triglyceride, was not assessed in the current study.
Given that endogenous substrates make significant contri-
butions to overall energy production in the heart and the
potential for gender-related differences to exist, it will be
important to directly measure catabolism of endogenous
substrates in future studies to determine their potential
contribution to the functional outcomes observed. In the
present study, contractile function of isolated working
hearts was assessed at a single preload and afterload set-
ting. A more comprehensive functional analysis using var-
ying preload and afterload settings may have produced
different results in male and female hypertrophied and
non-hypertrophied hearts. Similarly, exposure to low-
flow ischemia in contrast to no-flow ischemia may also
have resulted in different post-ischemic outcomes than
those in the current study. Future experiments will be
required to clarify these important issues.
Conclusion
Gender does not significantly influence post-ischemic
function of hypertrophied hearts, even though female sex
is detrimental to post-ischemic function of non-hypertro-
phied hearts. Differences in glucose catabolism may con-
tribute to hypertrophy-induced and gender-related
differences in post-ischemic function.
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